Efficacy and Safety of Once-Weekly Semaglutide Versus Daily Canagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes (SUSTAIN 8): A Double-Blind, Phase 3b, Randomised Controlled Trial

The Lancet Diabetes and Endocrinology - Netherlands
doi 10.1016/s2213-8587(19)30311-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Efficacy and Safety of Once-Weekly Semaglutide Monotherapy Versus Placebo in Patients With Type 2 Diabetes (SUSTAIN 1): A Double-Blind, Randomised, Placebo-Controlled, Parallel-Group, Multinational, Multicentre Phase 3a Trial

The Lancet Diabetes and Endocrinology
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

A Phase 3 Randomized Placebo-Controlled Trial to Assess the Efficacy and Safety of Ipragliflozin as an Add-On Therapy to Metformin in Russian Patients With Inadequately Controlled Type 2 Diabetes Mellitus

Diabetes Research and Clinical Practice
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2018English

Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-On to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2015English

Dose-Dependent Effects of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes Inadequately Controlled With Metformin: A Randomized, Double-Blind, Placebo-Controlled Trial

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Efficacy and Safety of Ipragliflozin Add‐on Therapy to Insulin in Japanese Patients With Type 1 Diabetes Mellitus: A Randomized, Double‐blind, Phase 3 Trial

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Efficacy and Safety of Teneligliptin Added Onto Canagliflozin Monotherapy in Japanese Patients With Type 2 Diabetes Mellitus: A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Comparative Study

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Hydroxychloroquine in Patients With Type 2 Diabetes Mellitus

Global Journal of Endocrinological Metabolism
2018English

Pdb67 - Once-Weekly Semaglutide Versus Dulaglutide for the Treatment of Patients With Type 2 Diabetes in Portugal: A Long-Term Cost-Effectiveness Analysis Based on Sustain 7

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Efficacy and Safety of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Frontiers in Pharmacology
Pharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy